Left, Sanger traces showing an ADNP nonsense mutation (A->T) present at the expected 50:50 ratio in the affected child (P1). smMIPs and the Sanger traces indicate the mother (MO) has the mutation at 10% allele frequency. Right, model of how the mutation arose mosaic in the mother and then was transmitted to affected offspring. (A-B) Analysis of SSC exome data (A) With the quad design we can compare the rates of somatic mosaic mutations in generations I and II. We can also compare and contrast the rates in affected and unaffected individuals. (B) We will identify and validate events consistent with mosaic events in the parent, which have now been transmitted to offspring through the germline. This will time the event to very early development (prior to gastrulation) where these cells had a common lineage. (C) Using high depth smMIP data we will determine whether any previously reported de novo mutations show evidence of low-level mosaicism in the parental blood DNA. Pedigree key: red fill=indicates approximate allele frequency of mutations; black fill=ASD diagnosis; squares=males; circles=females; filled; lightning=mutation event.
(A-B) Analysis of SSC exome data (A) With the quad design we can compare the rates of somatic mosaic mutations in generations I and II. We can also compare and contrast the rates in affected and unaffected individuals. (B) We will identify and validate events consistent with mosaic events in the parent, which have now been transmitted to offspring through the germline. This will time the event to very early development (prior to gastrulation) where these cells had a common lineage. (C) Using high depth smMIP data we will determine whether any previously reported de novo mutations show evidence of low-level mosaicism in the parental blood DNA. Pedigree key: red fill=indicates approximate allele frequency of mutations; black fill=ASD diagnosis; squares=males; circles=females; filled; lightning=mutation event.
Supplementary Figure 3:
Quantile-Quantile plot comparing proband (red) and sibling (blue) mutation simulation results from the ASD MIP plus exome combined data to a uniform distribution. Addition of exome sequencing data from 1,308 probands (1,157 ASD and 151 ID) and 803 unaffected controls highlights additional genes approaching significance that were not identified from MIP assay alone (Fig. 1b) . Note: Only a single mutation was observed for PFKFB2.
Supplementary Figure 4: Protein diagrams showing de novo mutation in ASD
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Network Trunc=gene was present in connected component of PPI network formed from only the truncating/splice exome events. Network Severe=gene was present in connected component of PPI network formed from the truncating/splice and severe missense exome events. Top gene in previous study=One of eight genes sequenced previously. 
Supplementary
# p-value for observing X or more total protein-altering events, and among them Y or more severe (trunc) events in 10 million simulations. 
